Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINT 1 pilot study of milrinone in neonates with persistent pulmonary hypertension of the newborn
2014-002988-16Phase 2Terminated
- Sponsor
- RCSI University of Medicine and Health Sciences
- Start
- Oct 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in persistent pulmonary hypertension of the newborn (PPHN) comparing Milrinone plus inhaled nitric oxide with Control with inhaled nitric oxide standard care (2 arms). Primary endpoints: Time on inhaled nitric oxide and Time on invasive ventilation. Started Oct 2014; status: terminated.
02
Drugs
milrinonenitric oxide
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on 2014-002988-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002988-16.